Results 171 to 180 of about 30,715 (288)

Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: An analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)

open access: yesAlzheimer's &Dementia, Volume 22, Issue 9, September 2026.
Abstract INTRODUCTION Postmenopausal estrogen decline may contribute to Alzheimer's disease (AD), but evidence linking circulating estrogens to cerebrospinal fluid (CSF) AD biomarkers remains limited. METHODS We analyzed 854 female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study with baseline serum estradiol ...
Juehyun Shin   +6 more
wiley   +1 more source

Editorial Commentary: Estrogen Influences Shoulder Health

open access: yesArthroscopy, Volume 42, Issue 9, Page 1538-1540, September 2026.
Abstract Estrogen influences bone mineral density, muscle quality and quantity, and collagen synthesis, rotator cuff tearing, worse outcomes after rotator cuff repair, hyperlaxity, and adhesive capsulitis. In this commentary, we discuss the potential explanations for the highly significant associations between hormonal systemic birth control and a ...
Peter Chalmers, Robert Tashjian
wiley   +1 more source

Systemic Hormonal Contraceptive Use Is Associated With Greater Odds of Rotator Cuff Tears, Shoulder Instability, Dislocation, and Other Shoulder Pathologies: A Propensity Matched Epidemiological Study

open access: yesArthroscopy, Volume 42, Issue 9, Page 1529-1537, September 2026.
Purpose To evaluate whether systemic estrogen‐only, progestin‐only, or combined hormonal contraceptives (HCs) are associated with increased risk of shoulder pathologies in reproductive‐age females. Methods A retrospective cohort study of female patients presenting to clinic from 2013 to 2020 and aged 13‐50 with 5 years of follow‐up was conducted using ...
Argen Omurzakov   +7 more
wiley   +1 more source

A Paradoxical Case of Bleeding and Clots: The Hidden Thrombotic Threat in Immune Thrombocytopenic Purpura

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Immune thrombocytopenic purpura (ITP) is typically characterized by mucocutaneous bleeding, yet paradoxical thrombotic events are increasingly recognized, particularly in patients treated with thrombopoietin‐receptor agonists (TPO‐RAs) such as eltrombopag.
Nayon Kumar Sarker   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy